Sort   by:  
 Page size 
UnknownHuman Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I.
Not available
S-EPMC7459140 | biostudies-literature
Unknown<i>In Vivo</i> Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix.
Not available
S-EPMC7642677 | biostudies-literature
UnknownSARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.
Not available
S-EPMC8420622 | biostudies-literature
UnknownNeutralising antibodies in Spike mediated SARS-CoV-2 adaptation.
Not available
S-EPMC7781345 | biostudies-literature
UnknownSARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies.
Not available
S-EPMC7899479 | biostudies-literature
UnknownSARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity.
Not available
S-EPMC9346021 | biostudies-literature
UnknownAge-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.
Not available
S-EPMC8373615 | biostudies-literature
UnknownSARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
Not available
S-EPMC8566220 | biostudies-literature
UnknownSARS-CoV-2 evolution during treatment of chronic infection.
Not available
S-EPMC7610568 | biostudies-literature
UnknownRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
Not available
S-EPMC8185188 | biostudies-literature
Sort   by:  
 Page size